Clinical trial
Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With…
NCT00309920 · Heinrich-Heine University, Duesseldorf, Other · Unknown status
Key facts
| NCT number | NCT00309920 |
|---|---|
| Title | Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast Cancer |
| Official title | Adjuvant Therapy of Breast Cancer: Impact of Erythropoiesis Stimulating Factors on Event Free Survival High Risk Breast Cancer Treatment |
| Lead sponsor | Heinrich-Heine University, Duesseldorf, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Biological, Drug |
| Interventions | darbepoetin alfa, cyclophosphamide, docetaxel, doxorubicin hydrochloride, epirubicin hydrochloride, fluorouracil |
| Enrollment | 1,234 |
| Start date | Jan 1, 2004 |
| First posted | Apr 3, 2006 |
| Last update posted | Feb 9, 2009 |
| Countries | Germany |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: